Sumitomo Life Insurance Co. acquired a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 5,639 shares of the medical research company’s stock, valued at approximately $749,000.
Other hedge funds have also recently bought and sold shares of the company. SHP Wealth Management bought a new position in Agilent Technologies during the fourth quarter valued at about $26,000. Core Wealth Advisors LLC bought a new stake in shares of Agilent Technologies during the 4th quarter worth about $26,000. Navalign LLC bought a new stake in shares of Agilent Technologies during the 4th quarter worth about $27,000. MV Capital Management Inc. acquired a new position in shares of Agilent Technologies during the 4th quarter valued at about $28,000. Finally, Entrust Financial LLC acquired a new position in shares of Agilent Technologies during the 4th quarter valued at about $31,000.
Analysts Set New Price Targets
Several research analysts recently commented on A shares. TD Cowen lifted their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Morgan Stanley raised their target price on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price target for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Barclays upped their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Finally, Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $160.24.
Agilent Technologies Stock Up 1.9%
A stock opened at $159.25 on Friday. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company has a market cap of $44.98 billion, a PE ratio of 31.98, a price-to-earnings-growth ratio of 2.81 and a beta of 1.25. The business’s 50-day simple moving average is $137.57 and its 200 day simple moving average is $126.23.
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
